Randomized trial of PDT vs. stent for palliation of malignant dysphagia: Cost-effectiveness and quality of life

被引:0
|
作者
Canto, MI
Smith, C
McClelland, L
Kantsevoy, S
Heath, E
Zahurak, M
Powe, N
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
600
引用
收藏
页码:AB100 / AB100
页数:1
相关论文
共 50 条
  • [21] Cost-effectiveness of the Hall Technique in a Randomized Trial
    Schwendicke, F.
    Krois, J.
    Robertson, M.
    Splieth, C.
    Santamaria, R.
    Innes, N.
    JOURNAL OF DENTAL RESEARCH, 2019, 98 (01) : 61 - 67
  • [22] Cost-effectiveness of the TAXUS™ paclitaxel-eluting coronary stent system vs. bare stent implantation in the diabetic population:: The TAXIJS']JS IV trial
    Clark, MA
    Bakhai, A
    Lavelle, T
    Berezin, R
    Shi, C
    Justason, B
    Natick, MA
    Stone, G
    Ellis, S
    Cohen, D
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 72E - 72E
  • [23] DAY-CARE FOR THE FRAIL ELDERLY - THE QUALITY OF LIFE VS COST-EFFECTIVENESS
    WEISMAN, C
    GERONTOLOGIST, 1984, 24 : 109 - 109
  • [24] Survival, stent patency, and cost-effectiveness of plastic biliary stent versus metal biliary stent for palliation in malignant biliary obstruction in a developing country tertiary hospital
    Farani, Muthia
    Saldi, Siti R. F.
    Maulahela, Hasan
    Abdullah, Murdani
    Syam, Ari F.
    Makmum, Dadang
    JGH OPEN, 2021, 5 (08): : 959 - 965
  • [25] Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia
    Ascher-Svanum, Haya
    Stensland, Michael D.
    Peng, Xiaomei
    Faries, Douglas E.
    Stauffer, Virginia L.
    Osuntokun, Olawale O.
    Kane, John M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (01) : 115 - 122
  • [26] Indoor Localization: A Cost-Effectiveness vs. Accuracy Study
    Mohebbi, Parisa
    Stroulia, Eleni
    Nikolaidis, Ioanis
    2017 IEEE 30TH INTERNATIONAL SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS (CBMS), 2017, : 552 - 557
  • [27] Response to: Ranibizumab vs. pegaptanib: a cost-effectiveness study?
    Luis Javier Hernández-Pastor
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2010, 248 : 1677 - 1677
  • [28] Response to: Ranibizumab vs. pegaptanib: a cost-effectiveness study?
    Javier Hernandez-Pastor, Luis
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (11) : 1677 - 1677
  • [29] Cost-effectiveness of Olanzapine vs. lithium in bipolar disorder
    Schaerer, LO
    Berns, S
    Born, C
    Brambilla, P
    Dobmeier, M
    Doppmann, T
    Graf, M
    Hartweg, V
    Hasmann, A
    Langosch, J
    Gerber, S
    Malliaris, Y
    Scott, HJ
    Seemüller, F
    Simhandl, C
    Torrent, C
    Trapp, W
    Wolf, J
    Grunze, H
    ACTA PSYCHIATRICA SCANDINAVICA, 2004, 110 : 35 - 35
  • [30] Cost-effectiveness of risedronate vs. Ibandronate: impact of persistence
    Grima, D.
    Pasquale, M.
    Lange, J.
    Thompson, M.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S157 - S158